Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Sharon

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Seminars in Oncology|June 25, 2018
PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinomaColleen S Curran, Elad Sharon
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Patterns of care and survival among patients with malignant mesothelioma in the United StatesLindsey Enewold, Elad Sharon, Anish Thomas
Cancer Discovery|August 6, 2025
Demographic Trends in NCI-Sponsored Early Phase Clinical trials (2000-2023): A Cohort StudyMaria Farooq, Elad Sharon, Naoko Takebe
Lymphatic Research and Biology|September 6, 2014
Lymphangiomatosis with dental involvementMordechai Findler, Avraham Hirshberg, Elad Sharon
JAMA Oncology|June 4, 2026
Fluids for Immune Checkpoint Inhibitor Diabetic Ketoacidosis-ReplyZoe Quandt, Megan Othus, Elad Sharon
Cancer|July 13, 2023
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth havingElad Sharon, Megan Othus, Zoe Eloise Quandt
Head & Neck Oncology|May 28, 2010
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabineElad Sharon, Ronan J Kelly, Eva Szabo
Lung Cancer (Amsterdam, Netherlands)|May 31, 2011
Chemotherapy and targeted therapies for unresectable malignant mesotheliomaRonan Joseph Kelly, Elad Sharon, Raffit Hassan
Oncology Research and Treatment|April 5, 2017
Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and VemurafenibLindsey Enewold, Elad Sharon, Linda C Harlan
Chinese Journal of Cancer|September 6, 2014
Immune checkpoint inhibitors in clinical trialsElad Sharon, Howard Streicher, Priscila Goncalves, et al.
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Seminars in Oncology|June 25, 2018
PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinomaColleen S Curran, Elad Sharon
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Patterns of care and survival among patients with malignant mesothelioma in the United StatesLindsey Enewold, Elad Sharon, Anish Thomas
Cancer Discovery|August 6, 2025
Demographic Trends in NCI-Sponsored Early Phase Clinical trials (2000-2023): A Cohort StudyMaria Farooq, Elad Sharon, Naoko Takebe
Lymphatic Research and Biology|September 6, 2014
Lymphangiomatosis with dental involvementMordechai Findler, Avraham Hirshberg, Elad Sharon
JAMA Oncology|June 4, 2026
Fluids for Immune Checkpoint Inhibitor Diabetic Ketoacidosis-ReplyZoe Quandt, Megan Othus, Elad Sharon
Cancer|July 13, 2023
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth havingElad Sharon, Megan Othus, Zoe Eloise Quandt
Head & Neck Oncology|May 28, 2010
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabineElad Sharon, Ronan J Kelly, Eva Szabo
Lung Cancer (Amsterdam, Netherlands)|May 31, 2011
Chemotherapy and targeted therapies for unresectable malignant mesotheliomaRonan Joseph Kelly, Elad Sharon, Raffit Hassan
Oncology Research and Treatment|April 5, 2017
Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and VemurafenibLindsey Enewold, Elad Sharon, Linda C Harlan
Chinese Journal of Cancer|September 6, 2014
Immune checkpoint inhibitors in clinical trialsElad Sharon, Howard Streicher, Priscila Goncalves, et al.
Pageof 20